scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0968-0896(98)00052-2 |
P698 | PubMed publication ID | 9730230 |
P50 | author | Fabrizio Manetti | Q37605198 |
P2093 | author name string | Botta M | |
Mongelli N | |||
Cappello V | |||
Ciomei M | |||
Corelli F | |||
Borgia AL | |||
Biasoli G | |||
P2860 | cites work | Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta | Q24563285 |
Three-dimensional structure of human basic fibroblast growth factor | Q24563295 | ||
Recent developments in the cell biology of basic fibroblast growth factor | Q24679568 | ||
Crystal structure of basic fibroblast growth factor at 1.6 A resolution | Q27647318 | ||
Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor | Q27729397 | ||
Heparin structure and interactions with basic fibroblast growth factor | Q27732601 | ||
Three-Dimensional Structures of Acidic and Basic Fibroblast Growth Factors | Q28267322 | ||
What Is the Evidence That Tumors Are Angiogenesis Dependent? | Q29620029 | ||
Preferential self-association of basic fibroblast growth factor is stabilized by heparin during receptor dimerization and activation. | Q33583925 | ||
Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin | Q33687824 | ||
Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma | Q34570747 | ||
Human tumor cells synthesize an endothelial cell growth factor that is structurally related to basic fibroblast growth factor | Q35599351 | ||
Suramin prevents neovascularisation and tumour growth through blocking of basic fibroblast growth factor activity | Q35994206 | ||
Growth factors and cancer | Q36441643 | ||
FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides. | Q38296447 | ||
Differential effects of suramin on the coupling of receptors to individual species of pertussis-toxin-sensitive guanine-nucleotide-binding proteins | Q41951760 | ||
New sulfonated distamycin A derivatives with bFGF complexing activity | Q42802546 | ||
Nature of the interaction of growth factors with suramin | Q42816405 | ||
Suramin binds to platelet-derived growth factor and inhibits its biological activity | Q42816663 | ||
Isolation of a tumor factor responsible for angiogenesis | Q42835506 | ||
A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site. | Q52352855 | ||
Differential inhibition of various deoxyribonucleic and ribonucleic acid polymerases by suramin. | Q54388450 | ||
An in vivo model for study of the angiogenic effects of basic fibroblast growth factor | Q56428784 | ||
A family of angiogenic peptides | Q59071772 | ||
Theoretical quantitative structure—activity relationship analysis on three dimensional models of ligand—m1 muscarinic receptor complexes | Q59614399 | ||
Synthesis of C-Alkyl Calix[4]arenes. 3. Acid-Catalyzed Rearrangement of 2,6-Dimethoxycinnamate Prior to Tetramerization to Calix[4]arenes | Q62085876 | ||
A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment | Q68948783 | ||
Inhibition of vacuolar H+-ATPases by fusidic acid and suramin | Q69920618 | ||
Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain | Q72326632 | ||
Diltiazem-like calcium entry blockers: a hypothesis of the receptor-binding site based on a comparative molecular field analysis model | Q73030694 | ||
Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells | Q93657789 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | suramin | Q425946 |
P304 | page(s) | 947-958 | |
P577 | publication date | 1998-07-01 | |
P1433 | published in | Bioorganic & Medicinal Chemistry | Q2904200 |
P1476 | title | Synthesis and binding mode of heterocyclic analogues of suramin inhibiting the human basic fibroblast growth factor | |
P478 | volume | 6 |
Q30668040 | Identification of inhibitors of heparin-growth factor interactions from combinatorial libraries of four-component condensation reactions |
Q34570156 | Molecular modeling as a powerful technique for understanding small-large molecules interactions. |
Q35033986 | Nanoscale growth factor patterns by immobilization on a heparin-mimicking polymer |
Q40206704 | Nature of Interaction between basic fibroblast growth factor and the antiangiogenic drug 7,7-(carbonyl-bis[imino-N-methyl-4,2-pyrrolecarbonylimino[N-methyl-4,2-pyrrole]-carbonylimino])-bis-(1,3-naphtalene disulfonate). II. Removal of polar interacti |
Q30493655 | Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compounds |
Q35812264 | Protein recognition using synthetic surface-targeted agents |
Q73803116 | Research on anti-HIV-1 agents. Investigation on the CD4-Suradista binding mode through docking experiments |
Q46639843 | Structural basis for antagonism by suramin of heparin binding to vaccinia complement protein |
Q34276825 | Synthesis of a heparan sulfate mimetic library targeting FGF and VEGF via click chemistry on a monosaccharide template |
Search more.